Harmony Biosciences Holdings, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Harmony Biosciences Holdings, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2023.
  • Harmony Biosciences Holdings, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $5.45M.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $5.45M Dec 31, 2023 10-K 2024-02-22
Q4 2021 $96.4M -$6.51M -6.33% Dec 31, 2021 10-K 2024-02-22
Q4 2020 $103M +$2.22M +2.2% Dec 31, 2020 10-K 2024-02-22
Q4 2019 $101M +$42.1M +72% Dec 31, 2019 10-K 2023-02-21
Q4 2018 $58.5M Dec 31, 2018 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.